Analysis Santhera’s Strategic Push: New Data Bolsters DMD Treatment Prospects
Santhera Pharmaceuticals is leveraging fresh clinical evidence to strengthen the market position of its flagship therapy, Agamree. The company recently presented new real-world data on vamorolone for treating Duchenne muscular...